Skip to content

Clinical trials

Completed Anemia, Refractory, with Excess of Blasts trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Refractory, with Excess of Blasts Status: Completed Country / region: Italy Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20101
20132
20141
20201
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondazione Italiana Sindromi Mielodisplastiche-ETS3
Traws Pharma, Inc.2
Advice Pharma Group srl1
European Organisation for Research and Treatment of Cancer - EORTC1
Gruppo Italiano Trapianto di Midollo Osseo1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Refractory, with Excess of Blasts9
Myelodysplastic Syndromes4
Cytopenia2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive2
Leukemia, Myeloid, Acute2
Leukemia, Myelomonocytic, Chronic2
Primary Myelofibrosis2
Amyloidosis1
Anemia, Aplastic1
Anemia, Refractory1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.